RecruitingPhase 4NCT07499804

Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes

Sponsor

Beni-Suef University

Enrollment

100 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Infertility, Female IVF

Summary

investigate the effect of different vasodilators as Tadalafil in women with unexplained infertility using IVF

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Tadalafil 5mg and a drug called estradiol valerate 2 mg for people with ivf and infertility, female. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 43 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTadalafil 5mg

phosphodiesterase type 5 (PDE-5) inhibitor

DRUGestradiol valerate 2 mg

estradiol valerate 2 mg. in form of (Cycloprogynova® Bayer Shering Pharma) white pills starting dose is one pill T.I.D may be increased to two pills T.I.D according to endometrial thickness in day 9 measured by vaginal ultrasound.